Effects of Ε11-Testolactone on the Pituitary-Testicular Axis In Oligospermic Men
Effects of Ε11-Testolactone on the Pituitary-Testicular Axis In Oligospermic Men
复制标题
Ε11-睾内酯对少精男性垂体-睾丸轴的影响
DOI:
--
复制
发表时间:
1981
期刊:
影响因子:
--
通讯作者:
A. Glass
中科院分区:
文献类型:
--
作者:
R. Vigersky;A. Glass
Ten men with idiopathic oligospermia were treated with E1testolactone (Teslac), a potent inhibitor of conversion of androgens to estrogens. Teslac therapy caused a fall i n serum estradiol and estrone levels of 34%(P < 0.01) and 41% (P< 0.01), respectively, and a rise in serum testosterone and androstenedione of 47% (p < 0.02) and 70%(P < 0.01), respectively. The testosterone:estradiol ratio increased by 126% (23.5 ± 2.5 × HT(1) to 45.2 ± 5.0 × 10-1; P < 0.01) and the androstene-dione:estrone ratio increased 231% (4.7 ± 0.6 × 10-1 to 12.9 ± 2.0 × 10-1; P< 0.01). Basal and LRH-stimulated serum gonadotro-pin levels were unaffected by these changes. Sperm density rose from 10.8 ± 2.5 to 19.8 ± 4.7 × 107ml (P < 0.01) and total sperm count from 26.8 ± 6.5 to 60.6 ± 14.3 × 106 (P < 0.001). There was no significant change in motility or semen volume. Three of the wives became pregnant. There were no adverse effects of Teslac administration. These data suggest that Teslac may be an effective treatment for men wit...